VC, K., MA, P., DJ, W., JL, R., H, B., R, D., . . . M, M. (2026). Clinical utility of a multianalyte lupus risk score incorporating cell-bound complement activation products: A systematic evaluation. Lupus science & medicine, 13(1), . https://doi.org/10.1136/lupus-2026-002002
Chicago Style (17th ed.) CitationVC, Kyttaris, et al. "Clinical Utility of a Multianalyte Lupus Risk Score Incorporating Cell-bound Complement Activation Products: A Systematic Evaluation." Lupus Science & Medicine 13, no. 1 (2026). https://doi.org/10.1136/lupus-2026-002002.
MLA (9th ed.) CitationVC, Kyttaris, et al. "Clinical Utility of a Multianalyte Lupus Risk Score Incorporating Cell-bound Complement Activation Products: A Systematic Evaluation." Lupus Science & Medicine, vol. 13, no. 1, 2026, https://doi.org/10.1136/lupus-2026-002002.